GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » Debt-to-Equity

Synbio Tech (ROCO:1295) Debt-to-Equity : 0.78 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Synbio Tech Debt-to-Equity?

Synbio Tech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$30.1 Mil. Synbio Tech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$701.7 Mil. Synbio Tech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$943.0 Mil. Synbio Tech's debt to equity for the quarter that ended in Dec. 2023 was 0.78.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Synbio Tech's Debt-to-Equity or its related term are showing as below:

ROCO:1295' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.59   Med: 0.65   Max: 0.78
Current: 0.78

During the past 4 years, the highest Debt-to-Equity Ratio of Synbio Tech was 0.78. The lowest was 0.59. And the median was 0.65.

ROCO:1295's Debt-to-Equity is ranked worse than
82.55% of 1060 companies
in the Biotechnology industry
Industry Median: 0.14 vs ROCO:1295: 0.78

Synbio Tech Debt-to-Equity Historical Data

The historical data trend for Synbio Tech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synbio Tech Debt-to-Equity Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
0.59 0.59 0.70 0.78

Synbio Tech Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Equity Get a 7-Day Free Trial 0.59 N/A 0.70 0.80 0.78

Competitive Comparison of Synbio Tech's Debt-to-Equity

For the Biotechnology subindustry, Synbio Tech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synbio Tech's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synbio Tech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Synbio Tech's Debt-to-Equity falls into.


Synbio Tech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Synbio Tech's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(30.069 + 701.697) / 942.969
=0.78

Synbio Tech's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(30.069 + 701.697) / 942.969
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech  (ROCO:1295) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Synbio Tech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Synbio Tech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Synbio Tech (ROCO:1295) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » Debt-to-Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
No.66,Beiling 6th Road, 821 Road, Luzhu District, Kaohsiung, TWN
Website
https://www.synbiotech.com
Synbio Tech Inc is a company specializing in the research, manufacturing and application development of lactic acid bacteria. They provide lactic acid bacteria screening, functional research and verification, and the introduction of advanced processes to produce safe and stable high-quality bacterial powder, OEM, ODM customized finished products , share application development technology, provide excellent service quality, and gain recognition from customers, allowing Shenghe to grow steadily.

Synbio Tech (ROCO:1295) Headlines

No Headlines